Royalty Pharma (RPRX) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for Royalty Pharma (RPRX) over the last 7 years, with Q4 2025 value amounting to $4.12.
- Royalty Pharma's Times Interest Earned fell 2497.86% to $4.12 in Q4 2025 from the same period last year, while for Dec 2025 it was $5.07, marking a year-over-year decrease of 1155.53%. This contributed to the annual value of $5.07 for FY2025, which is 1155.53% down from last year.
- Royalty Pharma's Times Interest Earned amounted to $4.12 in Q4 2025, which was down 2497.86% from $5.37 recorded in Q3 2025.
- In the past 5 years, Royalty Pharma's Times Interest Earned registered a high of $19.9 during Q2 2021, and its lowest value of -$10.28 during Q4 2022.
- In the last 5 years, Royalty Pharma's Times Interest Earned had a median value of $5.43 in 2025 and averaged $5.78.
- In the last 5 years, Royalty Pharma's Times Interest Earned crashed by 41473.06% in 2022 and then surged by 59075.96% in 2025.
- Over the past 5 years, Royalty Pharma's Times Interest Earned (Quarter) stood at $3.27 in 2021, then tumbled by 414.73% to -$10.28 in 2022, then skyrocketed by 226.18% to $12.97 in 2023, then crashed by 57.61% to $5.5 in 2024, then decreased by 24.98% to $4.12 in 2025.
- Its Times Interest Earned was $4.12 in Q4 2025, compared to $5.37 in Q3 2025 and $3.06 in Q2 2025.